Stemline Therapeutics - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsStemline Therapeutics

Stemline Therapeutics(STML)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Elzonris	Tagraxofusp	2018-12-21		Lymphoma , Malignant histiocytic disorders
Nexpovio	Selinexor	2021-03-26	2032-2035	Multiple myeloma
Orserdu	Elacestrant	2023-01-27	2024-2038	Breast neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

myelodysplastic syndromes

,

,

,

blastic plasmacytoid dendritic cell neoplasm

,

myeloid leukemia acute

,

,

,

myeloid leukemia

,

multiple myeloma

,

plasma cell neoplasms

,

primary myelofibrosis

,

myelomonocytic leukemia chronic

,

myelomonocytic leukemia acute

,

myelomonocytic leukemia juvenile

,

hematologic neoplasms

,

residual neoplasm

brain neoplasms

,

,

central nervous system neoplasms

,

central nervous system diseases

,

,

nervous system diseases

,

neoplasms by site

,

nervous system neoplasms

,

breast diseases

,

hereditary breast and ovarian cancer syndrome

,

breast neoplasms

,

triple negative breast neoplasms

,

male breast neoplasms

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

breast neoplasms

,

triple negative breast neoplasms

,

,

cystic fibrosis

,

pseudomonas infections

,

,

respiratory aspiration

Carboxymethylcellulose

,

essential hypertension

Globulin, immune

diabetes mellitus

,

type 1 diabetes mellitus

,

graft rejection

,

alpha 1-antitrypsin deficiency

,

graft vs host disease

,

,

pulmonary emphysema

breast neoplasms

,

healthy volunteers/patients

non-small-cell lung carcinoma

,

,

,

,

small cell lung carcinoma

,

,

breast neoplasms

,

non-hodgkin lymphoma

,

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

,

colonic neoplasms

healthy volunteers/patients

,

myelodysplastic syndromes

,

castration-resistant prostatic neoplasms

,

,

,

thromboembolism

,

,

,

,

myeloproliferative disorders

,

primary myelofibrosis

,

b-cell chronic lymphocytic leukemia

,

bcr-abl positive chronic myelogenous leukemia

,

myelomonocytic leukemia chronic

,

,

hodgkin disease

,

leukemia myeloid chronic atypical bcr-abl negative

,

myelodysplastic-myeloproliferative diseases

,

myeloid leukemia chronic-phase

,

myeloid leukemia accelerated phase

,

,

,

precursor b-cell lymphoblastic leukemia-lymphoma

,

,

endometrioid carcinoma

,

peritoneal neoplasms

,

hereditary breast and ovarian cancer syndrome

,

t-cell lymphoma

,

t-cell leukemia

,

ductal carcinoma breast

,

ductal carcinoma

,

invasive hydatidiform mole

,

,

unknown primary neoplasms

,

,

hepatic insufficiency

,

,

nervous system neoplasms

,

choroid plexus neoplasms

,

,

neuroepithelial neoplasms

,

renal insufficiency

,

,

,

adenocarcinoma of lung

,

,

cardiovascular diseases

,

,

,

immune system diseases

,

malignant fibrous histiocytoma

,

molecular targeted therapy

,

,

pancreatic neoplasms

,

non-small-cell lung carcinoma

,

,

,

,

non-hodgkin lymphoma

,

precursor cell lymphoblastic leukemia-lymphoma

,

colorectal neoplasms

,

head and neck neoplasms

,

prostatic neoplasms

,

multiple myeloma

,

,

kidney neoplasms

,

myeloid leukemia acute

,

lymphoid leukemia

,

,

colonic neoplasms

,

ovarian epithelial carcinoma

,

medulloblastoma

,

,

myeloid leukemia

,

hepatocellular carcinoma

,

urinary bladder neoplasms

,

liver neoplasms

,

mantle-cell lymphoma

,

,

,

hematologic neoplasms

,

fallopian tube neoplasms

,

brain neoplasms

,

,

,

rhabdomyosarcoma

,

,

esophageal squamous cell carcinoma

,

gastrointestinal neoplasms

,

esophageal neoplasms

,

uterine cervical neoplasms

,

rectal neoplasms

,

urologic neoplasms

,

urogenital neoplasms

,

central nervous system neoplasms

,

,

primitive neuroectodermal tumors peripheral

,

,

,

langerhans-cell histiocytosis

,

germ cell and embryonal neoplasms

,

primitive neuroectodermal tumors

,

neuroectodermal tumors

,

,

oligodendroglioma

,

pancreatic ductal carcinoma

,

,

,

digestive system neoplasms

,

stomach neoplasms

,

uterine neoplasms

,

,

plasma cell neoplasms

,

,

gastrointestinal stromal tumors

,

diffuse intrinsic pontine glioma

,

histiocytic sarcoma

,

juvenile xanthogranuloma

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

small cell lung carcinoma

,

intraductal carcinoma noninfiltrating

,

,

b-cell lymphoma

,

thymus neoplasms

,

neuroendocrine tumors

,

neuroendocrine carcinoma

,

islet cell carcinoma

,

transitional cell carcinoma

,

t-cell lymphoma peripheral

,

,

testicular neoplasms

,

,

,

,

,

thromboinflammation

,

hormone replacement therapy

,

hereditary sensory and autonomic neuropathies

,

kidney diseases

,

urologic diseases

,

glandular and epithelial neoplasms

,

salivary gland neoplasms

,

,

myxoid liposarcoma

,

high-throughput nucleotide sequencing

,

,

triple negative breast neoplasms

,

neoplasm metastasis

,

,

male breast neoplasms

,

,

squamous cell carcinoma of head and neck

,

squamous cell carcinoma

,

breast diseases

,

squamous cell neoplasms

,

neoplasms by site

,

,

unilateral breast neoplasms

,

neoadjuvant therapy

,

breast neoplasms

,

,

ovarian neoplasms

,

renal cell carcinoma

,

endometrial neoplasms

,

thyroid neoplasms

,

therapeutic equivalency

,

,

,

,

venous thromboembolism

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use